• Cardiology, Diabetes & Nephrology
    • Cardiology, Diabetes & Nephrology – London
    • Cardiology, Diabetes & Nephrology – Brazil
    • Cardiology, Diabetes & Nephrology – Canada
    • Cardiology, Diabetes & Nephrology – USA
    • Hatter Horizon Series
    • The 18th Malvern Diabetic Foot Conference
    • Previous Events
      • CDNATL 2019 – London
      • CDNATL 2019 – Brazil
      • CDNATL 2018
      • CDNATL 2017
      • CDNATL 2016
      • CDNATL 2015
      • CDNATL 2014
      • CDATL 2013
      • CDATL 2012
      • NATL 2012
      • CDATL 2011
      • CDATL 2010
      • NATL 2010
      • CATL 2009
      • NATL 2009
  • Cell Therapy
    • Cell Therapy at the Limits 2021
  • Oncology
    • Previous Events
      • Accelerating Cancer Immunotherapy 2017
      • OATL 2016
      • OATL 2015
      • OATL 2014
      • OATL 2012
      • OATL 2011
      • OATL 2010
      • UCL Frontiers of Oncology 2019
        • Haematology
        • Melanoma
        • Urology
        • Women’s Health
        • Lung Cancer
        • Gastrointestinal Oncology
        • Paediatric Oncology
        • Supporters
  • Multiple Sclerosis
    • Multiple Sclerosis at the Limits 2021
    • Multiple Sclerosis Nurses at the Limits 2021
    • Previous Events
      • Multiple Sclerosis Nurses at the Limits 2020
      • Multiple Sclerosis Nurses at the Limits 2019
      • MSATL 2018: Introduction
      • MSATL 2017: Introduction
  • About
    • Academic Founders
    • Independence
    • The Lancet
    • Support & Sponsorship
    • Delegate Invitations
  • Supporters
  • Archive
    • CDNATL 2019 – London
    • CDNATL 2019 – Brazil
    • Multiple Sclerosis at the Limits 2018
    • Multiple Sclerosis at the Limits 2020
    • Multiple Sclerosis Nurses at the Limits 2020
    • Multiple Sclerosis Nurses at the Limits 2019
    • Hatter Horizon Series
      • Horizon GP Programme 2019
      • Hatter Horizon Series 2019
      • Hatter Horizon Series 2018
      • Hatter Horizon Series 2017
    • Cardiology, Diabetes & Nephrology at the Limits 2018
    • Accelerating Cancer Immunotherapy 2017
    • Oncology at the Limits 2017

Professor Gary Cutter

Dr. Cutter is Professor of Biostatistics in the UAB School of Public Health in the Department of Biostatistics. Dr. Cutter has a major interest in design, analysis and interpretation of clinical trials, epidemiologic studies and evaluation research. He is currently directing the coordinating centers of multiple NIH randomized trials: the Early Biomarkers of Autism Spectrum Disorders in Infants with Tuberous Sclerosis Complex and the randomized Preventing Epilepsy Using Vigabatrin in Infants with Tuberous Sclerosis (PREVeNT trial) both NINDS funded studies. He is the Deputy Director of the Operations Center and Director of the Coordinating Center for Neurofibromatosis Consortium with 7 current ongoing trials. He directs the coordinating center for the NHLBI Chronic Hypertension in Pregnancy (CHAP) and is the director of the Autoantibody-Targeted Therapy for Acute Exacerbations of Idiopathic Pulmonary Fibrosis (STRIVE) clinical trial funded by NHLBI. He is the PI of the recently completed Trial of Thymectomy plus Prednisone versus Prednisone alone in the treatment of non-thymomatous Myasthenia Gravis (MGTx). He is the immediate past Director of the NARCOMS multiple sclerosis patient registry and current Director the Myasthenia Gravis patient registry. He is the Director, Biostatistics/Bioinformatics Resource (BBR) Core in the O’brien Center for Acute Kidney Injury Research, UAB-USC (NIDDK), UAB (NIAID) and Associate Director, National Center for High Impact Clinical Trials in Rehabilitation Medicine. He is the current President of the Consortium of MS Centers.

He is a member of numerous data and safety monitoring committees for the NIH, Pharmaceutical Companies and foundations as well as advisory committees. He serves on the International Clinical Trials Committee of the National MS Society and International MS Societies as well as being on the editorial board of the journal MS and writes a column Statistics for the Neurologist in Practice for Neurology for clinical practice as a contributing editor. He is an Associate Editor of Alzheimer’s Disease Translational Research. He is a member of the Statistics Editorial Board for the Journal of the American Society of Nephrology (JASN). He is a mentor on numerous K awards from across campus, PhD and master’s students and teaches in various national and international short courses.

« Professor Dr Bernard Uitdehaag
Professor Olga Ciccarelli »

Cardiology, Diabetes & Nephrology at the Limits Canada
Wednesday, 3 & Thursday, 4 March 2021, Virtual Meeting

Cardiology, Diabetes & Nephrology at the Limits 2021
Monday, 12 - Tuesday, 13 April 2021, London, UK

The 18th Malvern Diabetic Foot Conference
Wednesday, 12 – Friday, 14 May 2021, Malvern, UK

Hatter Horizon GP Meeting
Wednesday, 19 May 2021
London, UK

Hatter Horizon Series
Friday, 21 May 2021
London, UK

Multiple Sclerosis Nurses
at the Limits

Friday, 4 & Saturday, 5 June 2021, London, UK

Multiple Sclerosis at the Limits
Thursday, 24 & Friday, 25 June 2021, London, UK

Cardiology, Diabetes & Nephrology at the Limits Brazil
Friday, 16 - Saturday, 17 July 2021, São Paulo, Brazil

Cell Therapy at the Limits 2021
Wednesday, 21 & Thursday, 22 July 2021, London, UK

Policy links

  • Medical Disclaimer
  • Disclosure
  • E-mail Policy
  • Privacy Policy
  • Anti-spam Policy
  • Disclaimer
  • External Links Policy
  • Terms of use
  • Contact
  • The Lancet
  • UCL
  • UCT
  • Brigham & Women’s Hospital
  • The University of Campinas
© 2020 At the Limits Ltd.
This site uses cookies More info